AngioDynamicsANGO
About: AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Employees: 748
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
133% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 15
100% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]
14% more funds holding
Funds holding: 134 [Q4 2024] → 153 (+19) [Q1 2025]
9% more capital invested
Capital invested by funds: $303M [Q4 2024] → $330M (+$27.3M) [Q1 2025]
5.37% more ownership
Funds ownership: 81.41% [Q4 2024] → 86.79% (+5.37%) [Q1 2025]
22% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 58
31% less call options, than puts
Call options by funds: $351K | Put options by funds: $510K
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Yi Chen | 50%upside $16 | Buy Maintained | 7 Apr 2025 |
Financial journalist opinion
Based on 4 articles about ANGO published over the past 30 days









